Trabecular metal acetabular components in primary total hip arthroplasty

Inari Laaksonen, Michelle Lorimer, Kirill Gromov, Antti Eskelinen, Ola Rolfson, Stephen E Graves, Henrik Malchau, Maziar Mohaddes, Inari Laaksonen, Michelle Lorimer, Kirill Gromov, Antti Eskelinen, Ola Rolfson, Stephen E Graves, Henrik Malchau, Maziar Mohaddes

Abstract

Background and purpose - Trabecular metal (TM) cups have demonstrated favorable results in acetabular revision and their use in primary total hip arthroplasty (THA) is increasing. Some evidence show that TM cups might decrease periprosthetic infection (PPI) incidence. We compared the survivorship of TM cups with that of other uncemented cups in primary THA, and evaluated whether the use of TM cups is associated with a lower risk of PPI. Patients and methods - 10,113 primary THAs with TM cup and 85,596 THAs with other uncemented cups from 2 high-quality national arthroplasty registries were included. The mean follow-up times were 3.0 years for the TM cups and 3.8 years for the other uncemented cups. Results - The overall survivorship up to 8 years for TM cups and other uncemented cups was 94.4% and 96.2%, respectively (p = < 0.001). Adjusting for relevant covariates in a Cox regression model the TM cups had a persistently higher revision risk than other uncemented cups (HR =1.5, 95% CI 1.4-1.7, p = < 0.001). There was a slightly higher, though not statistically significant, revision rate for PPI in the TM group (1.2, 95% CI 1.0-1.6, p = 0.09). Interpretation - Risk of revision for any reason was higher for the TM cup than for other uncemented cups in primary THA. In contrast to our hypothesis, there was no evidence that the revision rate for PPI was lower in the TM cup patients. Regardless of the promising early and mid-term results for TM cups in hip revision arthroplasty, we would like to sound a note of caution on the increasing use of the TM design, especially in uncomplicated primary THAs, where uncemented titanium cups are considered to provide a reliable outcome.

Figures

Figure 1.
Figure 1.
Flowchart of patient selection.
Figure 2.
Figure 2.
Kaplan–Meier survival for TM cups and other uncemented cups in primary THA with revision for any reason as the end-point. 95% CI levels presented around the curves in light blue and light grey.
Figure 3.
Figure 3.
Kaplan–Meier survival for TM cups and other uncemented cups in primary THA with revision for infection as the end-point. 95% CI levels presented around the curves in light blue and light grey.

References

    1. AOANJRR. AOANJRR validation process. Available from: [last accessed December 12, 2017].
    1. AOANJRR. Annual Report 2016. Available from: [last accessed December 12, 2017].
    1. Baad-Hansen T, Kold S, Nielsen P T, Laursen M B, Christensen P H, Soballe K.. Comparison of trabecular metal cups and titanium fiber-mesh cups in primary hip arthroplasty: a randomized RSA and bone mineral densitometry study of 50 hips. Acta Orthop 2011; 82(2): 155–60.
    1. Beckmann N A, Weiss S, Klotz M C M, Gondan M, Jaeger S, Bitsch R G.. Loosening after acetabular revision: comparison of trabecular metal and reinforcement rings. A systematic review. J Arthroplasty 2014; 29(1): 229–35.
    1. Bobyn J D, Stackpool G J, Hacking S A, Tanzer M, Krygier J J.. Characteristics of bone ingrowth and interface mechanics of a new porous tantalum biomaterial. J Bone Joint Surg 1999; 81(5): 907–14.
    1. Dale H, Fenstad A M, Hallan G, Havelin L I, Furnes O, Overgaard S, et al. . Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop 2012; 83(5): 449–58.
    1. Dale H, Hallan G, Hallan G, Espehaug B, Havelin L I, Engesaeter L B.. Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop 2009; 80(6): 639–45.
    1. Davies J H, Laflamme G Y, Delisle J, Fernandes J.. Trabecular metal used for major bone loss in acetabular hip revision. J Arthroplasty 2011; 26(8): 1245–50.
    1. De Martino I, De Santis V, Sculco P K, D’Apolito R, Poultsides L A, Gasparini G.. Long-term clinical and radiographic outcomes of porous tantalum monoblock acetabular component in primary hip arthroplasty: a minimum of 15-year follow-up. J Arthroplasty 2016; 31(9): 110–14.
    1. Gundtoft P H, Overgaard S, Schønheyder H C, Møller J K, Kjaersgaard-Andersen P, Pedersen A B.. The incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties: a prospective cohort study. Acta Orthop 2015; 86(3): 326–34.
    1. Howard J L, Kremers H M, Loechler Y A, Schleck C D, Harmsen WS, Berry D J, et al. . Comparative survival of uncemented acetabular components following primary total hip arthroplasty. J Bone Joint Surg (Am) 2011; 93(17)1597–604.
    1. Huotari K, Peltola M, Jämsen E.. The incidence of late prosthetic joint infections: a registry-based study of 112,708 primary hip and knee replacements. Acta Orthop 2015; 86(3):3 21–5.
    1. Jafari S M, Bender B, Coyle C, Parvizi J, Sharkey P F, Hozack W J.. Do tantalum and titanium cups show similar results in revision hip arthroplasty? Clin Orthop Relat Res 2010; 468(2): 459–65.
    1. Jameson S S, Lees D, James P, Serrano-Pedraza I, Partington P F, Muller S D, et al. . Lower rates of dislocation with increased femoral head size after primary total hip replacement: a five-year analysis of NHS patients in England. J Bone Joint Surg (Br) 2011; 93: 876–80.
    1. Kremers H M, Howard J L, Loechler Y, Schleck C D, Harmsen W S, Berry D J, et al. . Comparative long-term survivorship of uncemented acetabular components in revision total hip arthroplasty. J Bone Joint Surg (Am) 2012; 94(12): e82.
    1. Lindgren J V, Gordon M, Wretenberg P, Kärrholm J, Garellick G.. Validation of reoperations due to infection in the Swedish Hip Arthroplasty Register. BMC Musculoskelet Disord 2014; 15: 384.
    1. Macheras G, Kateros K, Kostakos A, Koutsostathis S, Danomaras D, Papagelopoulos P J.. Eight- to ten-year clinical and radiographic outcome of a porous tantalum monoblock acetabular component. J Arthroplasty 2009; 24(5): 705–9.
    1. Mohaddes M, Rolfson O, Kärrholm J.. Short-term survival of the trabecular metal cup is similar to that of standard cups used in acetabular revision surgery. Acta Orthop 2015; 86(1): 26–31.
    1. Noiseux N O, Long W J, Mabry T M, Hanssen A D, Lewallen D G.. Uncemented porous tantalum acetabular components: early follow-up and failures in 613 primary total hip arthroplasties. J Arthroplasty 2014; 29(3): 617–20.
    1. Pulido L, Ghanem E, Joshi A, Purtill J J, Parvizi J.. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008; 466(7): 1710–15.
    1. Siegmeth A, Duncan C P, Masri B A, Kim W Y, Garbuz D S.. Modular tantalum augments for acetabular defects in revision hip arthroplasty. Clin Orthop Relat Res 2009; 467(1): 199–205.
    1. Skyttä E T, Eskelinen A, Paavolainen P O, Remes V M.. Early results of 827 trabecular metal revision shells in acetabular revision. J Arthroplasty 2011; 26(3): 342–5.
    1. Sternheim A, Backstein D, Kuzyk P R, Goshua G, Berkovich Y, Safir O, Gross A E.. Porous metal revision shells for management of contained acetabular bone defects at a mean follow-up of six years: a comparison between up to 50% bleeding host bone contact and more than 50% contact. J Bone Joint Surg Br 2012; 94(2): 158–62.
    1. Tokarski A T, Novack T A, Parvizi J.. Is tantalum protective against infection in revision total hip arthroplasty? Bone Joint J 2015; 97-B(1): 45–9.
    1. Weeden S H, Schmidt R H.. The use of tantalum porous metal implants for Paprosky 3A and 3B defects. J Arthroplasty 2007; 22(6Suppl): 151–5.
    1. Wegrzyn J, Kaufman K R, Hanssen A D, Lewallen D G.. Performance of porous tantalum vs. titanium cup in total hip arthroplasty: randomized trial with minimum 10-year follow-up. J Arthroplasty 2015; 30(6): 1008–13.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner